Zydus Lifesciences informs about press release

11 Dec 2023 Evaluate

Zydus Lifesciences has informed that it enclosed a copy of press release dated December 11, 2023 titled ‘Zydus and Daewoong Pharmaceutical announce exclusive licensing agreement for development and commercialization of Leuprolide Long-Acting Injectable in the U.S’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

870.75 -2.20 (-0.25%)
21-Jan-2026 10:54 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1620.80
Dr. Reddys Lab 1149.25
Cipla 1368.60
Zydus Lifesciences 870.75
Lupin 2158.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×